Advancing our proprietary technology platform
FOCUSED PIPELINE WITH STRONG GROWTH POTENTIAL AND THE POWER TO IMPROVE PATIENTS’ LIVES
We are driving our proprietary technology platform forward, with a focused pipeline that holds immense growth potential and the capability to enhance the lives of patients. Our innovative technology leverages the regenerative properties of a patient’s own skin to address various skin-related conditions. With robust clinical evidence and peer-reviewed publications supporting our approach, our late-stage pipeline concentrates on utilizing the RECELL® System to prepare and administer Spray-On Skin™ Cells for treating injuries and skin defects.
thermal burn wounds | full-thickness skin defects
Current clinical trials
Repigmentation of stable vitiligo lesions
RECELL provides point-of-care regenerative therapy for thermal burn wounds and full-thickness skin defects.